Cloud-clone
SKU:RPB889Hu01
Recombinant Cyclin Dependent Kinase 2 (CDK2)
Recombinant Cyclin Dependent Kinase 2 (CDK2)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPB889Hu01
Organism Species
Homo sapiens (Human).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Nucleus, Cytoplasm
Predicted Molecular Mass
13.3kDa
Accurate Molecular Mass
13kDa(Analysis of differences refer to the manual)
Residues & Tags
Ser94~Thr198 (Accession # P24941) with N-terminal His Tag
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Traits
Freeze-dried powder
Purity
> 97%
Isoelectric Point
7.9
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Leukemia & Lymphoma | The nanoparticulate Quillaja saponin KGI exerts anti-proliferative effects by down-regulation of cell cycle molecules in U937 and HL-60 human leukemia cells Pubmed: 24138332 |
| Future Medicinal Chemistry | Construction of some cytotoxic agents with aurone and furoaurone scaffolds pubmed:29235893 |
| Synthesis of Novel Heterocyclic Compounds Containing Benzothiophene of Expected Anticancer Activity. : |
